Siddu govt to follow High Court order on Kambala in Tulu Nadu

Bengaluru, Mar 26: Karnataka Primary and Higher Education Minister Suresh Kumar on Thursday clarified that the SSLC examinations have not canceled as being claimed by many. 

Taking to Twitter, he said there was confusion among students and parents as wrong news was published in a some of the news papers and even in social media also.

Bengaluru, Feb 8: The Department of Religious Endowments in Karnataka will undertake 'Ratha Yatras' in 110 major temples of the state, in order to inform the public about mass marriages, scheduled to be held on April 26.

The publicity campaign through Rath Yatra will be flagged off from Mookambika temple in Kollur of Udupi district from February 13.

The mass marriage programme 'Saptapadi,' would be held in 100 major temples of Muzrai department. The second phase would be held on May 24, Minister for Ports, Fisheries and Muzrai Kota Srinivas Poojary told newspersons here on Friday.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.